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Abstract Stress-activated protein kinases are MAP kinase 
homologues that are activated by cellular stresses, bacterial 
endotoxin and inflammatory cytokines. They are activated by a 
dual threonineJtyrosine phosphorylation within a TPY sequence 
in the case of stress-activated protein kinase-1 and its isoforms 
(also called JNKs) or a TGY sequence in the case of stress- 
activated protein kinase-2 and its isoforms (also called p38, p40, 
RK, CSBPs, XMpk2 and Mxi2). Here we report the cloning and 
sequencing of a new protein kinase from rat with a TGY 
sequence in the activation domain. This stress-activated protein 
kinase-3 is 60% identical to mouse stress-activated protein 
kinase-2 and 45% identical to HOG1 from Saccharomyces 
cerevisiae. Transcripts encoding stress-activated protein kinase-3 
are widely expressed, with high levels in skeletal muscle. 
g~,y words: Mitogen-activated protein kinase; Stress- 
at:tivated protein kinase; Stress-activated protein kinase-3; 
HOG1 
I. Introduction 
Mitogen-activated protein (MAP) kinases play important 
r~'.les in signal transduction pathways in eukaryotic ells (re- 
viewed in [1-3]). They are activated through phosphorylation 
b~' upstream cascades of protein kinases, resulting in a sub- 
slantial amplification of the primary signal. The activation of 
the upstream kinase cascades i , in turn, triggered by a num- 
b~r of signalling molecules, chiefly growth factors. Once acti- 
wtted, MAP kinases phosphorylate a number of cytoplasmic 
a~td nuclear proteins, including some transcription factors, 
thereby effecting changes in gene expression. Activation of 
p42/p44 MAP kinases is sufficient o induce the proliferation 
o~ differentiation of several cell types. MAP kinases that par- 
ti,:ipate in the growth factor-stimulated pathway are actived 
~hen a threonine and a tyrosine residue in a TEY sequence in 
k:nase subdomain VIII just N-terminal to the conserved APE 
n~otif are phosphorylated. The activation is catalysed by the 
dJlal specificity enzymes MAP kinase kinase 1 (also called 
I~IEK1) or MAP kinase kinase 2 (also called MEK2) which 
pilosphorylate both residues. 
Two MAP kinase homologues have been identified in mam- 
n~alian cells; they are activated by cellular stresses (chemical, 
h~'at and osmotic shock, ultraviolet radiation or inhibitors of 
wotein synthesis), by bacterial endotoxin and by the inflam- 
n-~atory cytokines interleukin-1 and tumour necrosis factor-ct 
a~ld have consequently been named stress-activated protein 
*~3orresponding author. Fax (44) (01223) 412282. 
Tae nucleotide sequence data reported in this paper will appear in the 
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(SAP) kinases [3]. Isoforms of SAP kinase-1 (also called 
JNKs) phosphorylate several transcription factors, such as 
c-Jun, ATF2, TCF/Elk-1 and p53 [4-9], and this has been 
shown to result in a stimulation of the transactivation func- 
tions of some of these proteins [4-8]. Isoforms of SAP kinase- 
2 (also called p38, p40, RK, CSBPs, XMpk2 and Mxi2) phos- 
phorylate the transcription factor ATF2 and MAP kinase- 
activated protein (MAPKAP) kinase-2, one of whose intracel- 
lular targets is the small heat shock protein HSP27 [10-15]. 
Like MAP kinases, SAP kinases are activated by a dual threo- 
nine/tyrosine phosphorylation, with a TPY motif for SAP 
kinase-I [4,5] and a TGY motif for SAP kinase-2 
[10,11,13,15,16]. Although MAP kinase kinase 3 and MAP 
kinase kinase 4 (also known as SEK1 or JNKK) have been 
shown to activate SAP kinases [17-19], it appears likely that 
additional protein kinases are involved in their physiological 
activation [20,21]. 
At present, SAP kinase-2 and its alternatively spliced iso- 
forms are the only known protein kinases from multicellular 
organisms with a TGY sequence in subdomain VIII. They are 
most similar to HOG1, a MAP kinase homologue from S. 
cerevisiae which lies in a signalling pathway that restores the 
osmotic gradient across the yeast cell membrane in response 
to high external osmolarity [22]. SAP kinase-2 and HOG1 
both contain a TGY sequence in an equivalent position to 
the TEY sequence in MAP kinases and the TPY sequence 
in SAP kinase-1. We now report the cloning and sequencing 
of a novel protein kinase from rat with a TGY sequence in the 
activation domain. This protein kinase (which we call SAP 
kinase-3) is 60% identical to mouse SAP kinase-2 and 45% 
identical to HOG1. By Northern blotting we show that SAP 
kinase-3 mRNA is widely expressed, with high levels in skel- 
etal muscle. 
2. Materials and methods 
2.1. PCR, cDNA cloning and sequencing 
A number of degenerate oligonucleotides were designed based on 
conserved kinase subdomains and used as polymerase chain reaction 
(PCR) primers to isolate and clone fragments of protein kinase 
cDNAs from adult rat brain cDNA. One set of primers from kinase 
subdomains I [5'-AA(A/G)AT(A/C/T)GG(T/C/A/G)GA(AJG)GG(T/ 
C/A/G)AC(T/C/A/G)TA(T/C)GG-Y, sense, for KIGEGTYG] and 
VII [5'-CC(A/G)AA(AIG)TC(TICIA/G)A(A/G)(TIGIA)AT(TIC)TT- 
Y, anti-sense, for KILDFG] produced a clone that exhibited a high 
degree of sequence similarity with SAP kinase-2 (PCR conditions: 
1 min 94°C, 1 min 48°C, 1 min 72°C, for 33 cycles, with a 10 min 
elongation i  the last cycle). This PCR fragment was then used as a 
probe to screen a rat brain cDNA library (Clontech) at high-strin- 
gency. One partial clone of 600 bp (clone rSAPK31) was obtained 
after screening 106 phage. Following sequencing the insert was gel- 
purified, labelled with [s2P]dCTP by random priming and used as a 
probe to screen a rat skeletal muscle cDNA library (Clontech) under 
high-stringency conditions. 24 hybridisation-positive clones were ob- 
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tained after screening 100000 plaques; 12 clones were isolated, sub- 
cloned into M13mpl8 and partially sequenced. Sequencing was per- 
formed both manually using synthetic oligonucleotides a primers and 
on an Applied Biosystems 377 DNA sequencer with fluorescent prim- 
ers. Full-length sequence was compiled from both strands of cDNA 
clone rSAPK37. The EMBL, Swissprot, GSDB and dBEST sequence 
databases were searched using the FastA algorithm via the GenQuest 
integrated sequence comparison server (GRAILMAIL@ornl.gov) and 
the EBI network file server (Fasta@ebi.ac.uk). A multiple alignment 
of SAP kinase-3, SAP kinase-2 and HOG1 was built up by eye, based 
on the optimal alignments of each pair of sequences produced by the 
Align program [23]. 
2.2. RNA blot analysis 
RNA blots were performed using the rat multiple tissue Northern 
blot from Clontech, with 2 I.tg poly(A) + RNA per lane. Probes were 
labelled with [32P]dCTP by random priming and hybridised under 
high-stringency onditions. The SAP kinase-3 probe was prepared 
from the gel-purified insert of the partial brain cDNA clone 
rSAPK31. The human [~-actin cDNA probe was purchased from 
Clontech. 
GTTGGCGGCTATACAGAGTTCAGGGTGGCGACCCCGAGAG~GAGCCCGCAAAGGAAAGC 60 
CCCAGAGGCGGGCAGGCGGGTGGCCGGCGCGGAGCCGGCCCTGCCACGCAGTGACCCGGG 120 
GCGCACGGGCGGAGCCCCTGATCCC~GTCCGGTCCTAGAGCGCGGTGCTCCGGCCGGGG 180 
M S S P P P A R K G F Y R Q E V T K T A  20 
ATGAGCTCCCCGCCACCCGCCCGC~GGGCTTTTACCGCCAGGAGGTGACCAAAACGGCC 240 
W E V R A V Y Q D L Q P V G S G A Y G A  40 
TGGGAGGTGCGCGCCGTGTACCAGGACCTGCAGCCCGTTGGCTCTGGTGCCTATGGTGCA 300 
V C S A V D S R T G N K V A I K K L Y R  60 
GTGTGCTCTGCAGTAGACAGCCGCACTGGC~C~GGTGGCCATC~G~GTTGTACCGG 360 
P F Q S E L F A K R A Y R E L R L L K H  80 
CCCTTCCAGTCGGAGCTGTTTGCC~GCGCGCCTACAGAGAGTTGCGCCTCCTCAAACAC 420 
M R H E N V I G L L D V F T P D E T L D  100 
ATGCGCCACGAG~CGTCATTGGGCTGCTGGATGTGTTCACTCCCGATGAGACTCTGGAT 480 
D F T D F Y L V M P F M G T D L G K L M  120 
GACTTCACAGACTTCTACCTGGTGATGCCATTCATGGGCACTGACCTGGGC~GCTCATG 540 
K H E T L S E D R I Q F L V Y Q M L K G  140 
~GCACGAGACTCTGAGTG~GACAG~TCCAGTTTCTTGTGTATCAGATGCTG~GGGG 600 
L K Y I H A A G V I H R D L K P G N L A  160 
CTG~GTATATCCACGCTGCCGGCGTCATCCACAGGGACTTGAAACCTGGAAACCTGGCT 660 
V N E D C E L K I L D F G L A R Q A D S  180 
GTG~CGAGGACTGTGAGCTG~GATCCTAGATTTTGGCCTTGCCAGGCAGGCGGACAGT 720 
E M T G Y V V T R W Y R A P E V I L N W  200 
GAGATGACAGGATATGTGGT~CCCGGTGGTATCGGGCACCAGAGGTCATCTTG~TTGG 780 
M R Y T Q T V D I W S V G C I M A E M I  220 
ATGCGTTACACACAGACAGTGGACATTTGGTCTGTTGGCTGCATCATGGCAGAGATGATT 840 
T G K I L F K G N D H L D Q L K E I M K  240 
ACTGGAAAGATCCTGTTCAAAGGC~TGACCACCTGGAC~GCTG~GGAGATCATGAAA 900 
V T G T P P P E F V Q K L Q S A E A K N  260 
GTCACAGGGACACCCCCTCCTGAGTTTGTACAG~GCTACAGAGTGCTGAGGCC~G~C 960 
Y M E G L P E L E K K D F A S V L T N A  280 
TACATGG~GGCCTCCCTGAGTTGGAAAAG~GGATTTTGCTTCTGTCCTGACC~TGCA 1020 
S P Q A V N L L E K M L V L D A E Q R V  300 
AGCCCTCAGGCCGTG~TCTCCTGGAAAAGATGCTGGTGTTGGATGCGG~CAGCGGGTG 1080 
T A A E A L A H P Y F E S L R D T E D E  320 
ACAGCAGCTGAGGCATTAGCCCACCCATACTTTGAGTCCCTTCGGGACACTGAGGATGAG 1140 
P K A Q K Y D D S F D D V D R T L E E W  340 
CCC~GGCCCAGAAATATGATGACTCCTTTGATGACGTAGACCGCACCCTTGAGG~TGG 1200 
K R V T Y K E V L S F K P P R Q L G A R  360 
~GCGTGTTACGTAT~GG~GTGCTCAGCTTC~GCCTCCCAGGCAGCTAGGAGCCAGA 1260 
V P K E T A L *  367 
GTTCCAAAGGAGACAGCTCTGTG~GACCTCCGGGTGGTTTGGGGGGTATCCT~GGAGG 1320 
CTGTCTGGGAGCTTCGCAGACACCTTGGCTTCCCTTCTCCGG~GAGG~TCCTGGTTGG 13BO 
CACCAGTGCCTGGTGCTTTTATCCC~GTCATCCACCTGGAAAGGCTGTGTAGACCCCTT 1440 
GAATCACG~CCCTCCATCTCC~GCCAGTTCTTCAGATTTTGAGCGCCCGAGATGACCC 1500 
TGGCAG~CATCT~GCTTTTTTTTTTTCTTTTTTCTTTTTTTCGGAGCTGGGGACCG~ 1560 
CCCAGGGCCTTGCGCTTGCTAGGC~GCGCTCTACTACTGAGCTAAATCCCC~CCCCAC 1620 
ATCT~GCTTTCTGTCC~GACCCCTACCC~CATGGGACTAGCC 1665 
Fig. I. Nucleotide and predicted amino acid sequence of rat SAP 
kinase-3. Nucleotides are numbered in the 5' to 3' direction and the 
amino acids are shown in single-letter code above the nucleotide se- 
quence. In-frame termination codons are marked by an asterisk. 
SAPK2 MSQEmPT 27 
HOG1 MTTNEEBBIIIITQIFGIBVFINITNNNNN 26 
SAPK3 
SAPK2 
HOG1 
SAPK3 
SAPK2 
HOG1 
S H 57 
N IN IMNFmL~HiL I IS  O P N !  M K 56 
SAPK3 |OET IDDiT IF |P~/eKBM 
SAPK2 IARS|EEBNBVI IH I~NNIV  
HOG1 mI I  . . . . .  ISPLE I I I F IE IO / IHR IL  
SAPK3 
SAPK2 
HOG1 
SAPK3 
SAPK2 
HOG1 
• • 
SAPK3 
SAPK2 
HOG1 
90 
87 
86 
120 
117 
111 
150 
147 
141 
180 
177 
171 
210 
207 
201 
SAPK3 ~ I ~ N N L I E N M K  240 
SAPK2 ~ T N T N I ~ L B L R  237 
HOG1 iAa iFNENPNKNVHNFSIBTD 231 
HOG1 IL~iKDVINTmCiNTLKFVTNmIHRDP 261 
SAPK3 KDI$~LTNBSBQN~AEQ~V 300 
SAPK2 MNIN I~IG IN IL~I~SD ~ 297 
HOG1 IP ISER IKTVE ID~FNPK i 291 
SAPK3 
SAPK2 
HOG1 
~m 329 
326 
NH 321 
SAPK3 iO iVNRTLE/RV IK /KNROLGA 3S9 
SAPK2 BESRNL I~L~~VNPLDQE 356 
HOGI IN~NPV~VMM~SBHKIGGSDG 351 
SAPK3 RVPKETAL 367 
SAPK2 EMES 360 
HOG1 QIDISATFDDQVAAATAAAAQAQAQAQAQV 381 
HOG1 QLNMAAHSHNGAGTTGNDHSDIAGGNKGQR 411 
HOG1 SCSCK 416 
Fig. 2. Sequence comparison of rat SAP kinase-3, mouse SAP ki- 
nase-2 [10] (also called p38, p40, RK, CSBP2 and XMpk2) and 
HOG1 from S. cerevisiae [22]. Amino acids were aligned and two 
gaps were introduced to maximise the homology. Amino acid identi- 
ties between at least two of the three sequences are indicated by 
black bars. Asterisks denote phosphorylation sites in the TGY se- 
quence of the activation domain. 
3. Results and discussion 
To identify novel members of the MAP kinase and SAP 
kinase group, we employed a PCR strategy using degenerate 
primers to amplify sequences from rat brain cDNA. Sequence 
analysis of PCR products led to the identification of one 
cDNA fragment hat exhibited homology to known SAP ki- 
nases. This fragment was used as a probe to screen an adult 
rat brain cDNA library at high-stringency and partial cDNA 
clone rSAPK31 was in turn used to screen a cDNA library 
from rat skeletal muscle. Screening of 100 000 plaques gave 24 
positives, several of which contained the entire coding region. 
The nucleotide and deduced amino acid sequence of cDNA 
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clone rSAPK37 is shown in Fig. 1. In-frame termination co- 
d(ms in the 5' and 3' regions of the DNA sequence indicate 
that it contains the entire coding region. A single open reading 
frame encodes a protein of 367 amino acids, with a predicted 
molecular mass of 42 kDa. It possesses the conserved amino 
acid domains (I-XI) characteristic of protein kinases and 
shows 60% sequence identity with mouse SAP kinase-2, 45% 
identity with HOG1 from S. cerevisiae (Fig. 2), 47% identity 
wth human SAP kinase-1 (JNK1) and 42% identity with p42 
MAP kinase (ERK2) from rat. The Thr ls3 and Tyr 185 residues 
in subdomain VIII are in an equivalent position to the TEY, 
T!~Y or TGY sequences in known MAP kinases and SAP 
klaases, phosphorylation of which is required for enzymatic 
attivity. The sequence shares a TGY sequence with SAP ki- 
rose-2 and HOG1. Moreover, as in SAP kinase-2 and HOG1, 
klaase subdomain VII is separated by only 6 amino acids 
fr)m the activation region in subdomain VIII, whereas the 
gz,p is 8 residues in SAP kinase-1 and over 12 amino acids 
in known MAP kinases. The predicted amino acid sequence 
a id  overall structure identify this protein as a novel member 
o! the SAP kinase-2 family that we designate SAP kinase-3. 
S~-P kinase-2 has been shown to exist as different isoforms 
A 1 2 3 4 5  67  8 
9.5 -  
7.5 -  
4 .4 -  
2 .4 -  
1 .4-  
B 
F~g. 3. RNA blot analysis of poly(A) + RNA from adult rat tissues, 
w~th 32p-labelled SAP kinase-3 (A) or I~-actin DNA (B) used as the 
probe. The blot was re-hybridised with the actin probe following 
elation of the SAP kinase-3 signal. Size markers (in kb) are marked 
to the left in (A). Lanes: 1, heart; 2, brain; 3, spleen; 4, lung; 5, 
fixer; 6, skeletal muscle; 7, kidney; 8, testis. 
resulting from alternative mRNA splicing [13,14]. It remains 
to be seen whether the same is true of SAP kinase-3. It also 
remains to be seen whether additional mammalian protein 
kinases exist with a TGY sequence in the activation domain. 
A recent study [24] has reported the sequence of a trapped 
exon from a human chromosome 22 cosmid library (accession 
number H55067) that is 88% identical to nucleotides 438~196 
from rat SAP kinase-3 and completely identical to the corre- 
sponding nucleotide sequence of human SAP kinase-3 (our 
unpublished observation). The human SAP kinase-3 gene 
therefore probably maps to chromosome 22. 
To examine the tissue distribution of SAP kinase-3, we used 
RNA blot analysis to investigate the levels of SAP kinase-3 
mRNA (Fig. 3). A cDNA probe specific for SAP kinase-3 
recognised a major transcript of approx. 2.2 kb (Fig. 3A). 
This size is larger than the DNA sequence shown in Fig. 1, 
suggesting that it lacks untranslated sequence; this is also 
indicated by the absence of a poly(A) tail at the 3' ends of 
the cDNA clones. SAP kinase-3 mRNA is widely expressed, 
with high levels in skeletal muscle (Fig. 3A). In some tissues a 
transcript of approx. 3.6 kb was observed in addition to the 
2.2 kb band. It is at present unclear whether this transcript 
results from alternative splicing, alternative polyadenylation, 
or whether it indicates the existence of a closely related gene. 
Re-hybridisation of the blot with a human 13-actin probe 
showed that comparable amounts of poly(A) + RNA had 
been loaded in each lane (Fig. 3B). The tissue distribution 
of rat SAP kinase-3 mRNA is similar to that of human 
SAP kinase-2 mRNA [13] which is also expressed at high 
levels in skeletal muscle. 
SAP kinase-2 is activated by various cellular stresses, by 
bacterial endotoxin and by inflammatory cytokines [10,13- 
15]. It will be interesting to determine whether the same is 
true of SAP kinase-3. Similarly, it will be important o iden- 
tify the SAP kinase kinases that activate SAP kinase-3, as well 
as its downstream targets. This will show whether SAP kinase- 
2 and SAP kinase-3 are activated by a common pathway or 
whether they form part of parallel signal transduction path- 
ways, each with its own specific downstream targets. SAP 
kinase-2 is the only known protein kinase that is inhibited 
by a novel class of pyridinyl imidazoles called CSAIDs, which 
were developed as inhibitors of the lipopolysaccharide-in- 
duced synthesis of interleukin-1 and tumour necrosis factor 
in monocytes, suggesting that activation of SAP kinase-2 re- 
sults in protein phosphorylation events which trigger cytokine 
gene transcription [13]. Moreover, CSAIDs inhibit the activa- 
tion of MAPKAP kinase-2 and the phosphorylation of 
HSP27 in viva in response to cellular stresses, bacterial endo- 
toxin and inflammatory cytokines [25]; they also inhibit the 
stimulation of 2-deoxyglucose uptake in response to interleu- 
kin-1 and anisomycin [26]. It will be interesting to determine 
whether CSAIDs inhibit SAP kinase-3. 
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